GADD45G has been demonstrated to induce senescence in HCC and reduce tumor growth in vivo. Moreover, GADD45G-induced senescence can be efficiently counteracted with Shp2 silencing. This evidence concerns the gene PTPN11 and hepatocellular carcinoma.